Profil
Khalid Ahmed Fakhroo is currently the Vice Chairman at National Mass Housing SAOC and the Director at Flat6Labs.
He also holds the position of Director & Chief Research Officer at Sidra Medicine since 2014.
Dr. Fakhroo completed his undergraduate degree at The University of Chicago in 2005 and obtained an MBA from Yale University in 2011.
Postes actifs de Khalid Ahmed Fakhroo
| Sociétés | Poste | Début |
|---|---|---|
National Mass Housing SAOC
National Mass Housing SAOC Real Estate DevelopmentFinance Provides real estate housing services | Directeur/Membre du Conseil | - |
Flat6Labs
Flat6Labs Investment ManagersFinance Flat6Labs invests companies located in MEA. The firm targets companies operating in the fields of SaaS, fintech, edtech, gaming, on-demand services, healthtech, e-commerce, fashion and beauty. It provides financing for early and seed stage capital with an investment size ranging between USD 0.05 to 0.5 million in exchange of minority stake with follow-on investment between USD 0.05 to 0.5 million. | Directeur/Membre du Conseil | - |
Sidra Medicine | Corporate Officer/Principal | 01/06/2014 |
Formation de Khalid Ahmed Fakhroo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Mass Housing SAOC
National Mass Housing SAOC Real Estate DevelopmentFinance Provides real estate housing services | Finance |
Flat6Labs
Flat6Labs Investment ManagersFinance Flat6Labs invests companies located in MEA. The firm targets companies operating in the fields of SaaS, fintech, edtech, gaming, on-demand services, healthtech, e-commerce, fashion and beauty. It provides financing for early and seed stage capital with an investment size ranging between USD 0.05 to 0.5 million in exchange of minority stake with follow-on investment between USD 0.05 to 0.5 million. | Finance |
Sidra Medicine |
















